The efficacy of tranexamic acid in reducing blood loss in total shoulder arthroplasty: A meta-analysis

The purpose of this meta-analysis is to compare the efficacy of tranexamic acid (TXA) versus placebo after a total shoulder arthroplasty (TSA). In April 2017, a systematic computer-based search was conducted in the databases of PubMed, Embase, Web of Science, Cochrane Library, and Google. Studies co...

Full description

Saved in:
Bibliographic Details
Published in:Medicine (Baltimore) 2017-09, Vol.96 (37), p.e7880-e7880
Main Authors: He, Jing, Wang, Xi-e, Yuan, Guo-Hong, Zhang, Lian-Hai
Format: Article
Language:English
Subjects:
Antifibrinolytic Agents - therapeutic use
Arthroplasty, Replacement, Shoulder
Blood Loss, Surgical - prevention & control
Humans
Systematic Review and Meta-Analysis
Tranexamic Acid - therapeutic use
Treatment Outcome
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c2851-ab6407f0736d9d8a6638789e1bdf5a4140a26f5c1b0427ae5f116ed8f157ece43
container_end_page e7880
container_issue 37
container_start_page e7880
container_title Medicine (Baltimore)
container_volume 96
creator He, Jing
Wang, Xi-e
Yuan, Guo-Hong
Zhang, Lian-Hai
description The purpose of this meta-analysis is to compare the efficacy of tranexamic acid (TXA) versus placebo after a total shoulder arthroplasty (TSA). In April 2017, a systematic computer-based search was conducted in the databases of PubMed, Embase, Web of Science, Cochrane Library, and Google. Studies comparing TXA versus placebo in reducing blood loss after TSA were included. The endpoints were the need for transfusion, blood loss in drainage, hemoglobin drop, and total blood loss. Stata 12.0 software was used for the meta-analysis. Six studies involving a total of 637 patients met the inclusion criteria. The meta-analysis revealed that, compared with control groups, treatment with TXA could decrease the need for transfusion (P 
doi_str_mv 10.1097/MD.0000000000007880
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5604638</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1938849889</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2851-ab6407f0736d9d8a6638789e1bdf5a4140a26f5c1b0427ae5f116ed8f157ece43</originalsourceid><addsrcrecordid>eNpdUU1v1DAQtRCILoVfgIR85JJiJ_7kgFS1fEmtuJSzNXHGjcEbL3ZC2X9PypaqMJeRZt68NzOPkJecnXBm9ZvL8xP2ILQx7BHZcNmpRlolHpMNY61stNXiiDyr9RtjvNOteEqOWmOZ6pTdkHA1IsUQoge_pznQucCEv2AbPQUfBxonWnBYfJyuaZ9yHmjKtd6W5zxDonXMSxqwUCjzWPIuQZ33b-kp3eIMDUyQ9jXW5-RJgFTxxV0-Jl8_vL86-9RcfPn4-ez0ovGtkbyBXgmmA9OdGuxgQKnOaGOR90OQILhg0KogPe-ZaDWgDJwrHEzgUqNH0R2Tdwfe3dJvcfA4rfcktytxC2XvMkT3b2eKo7vOP51UTKxiK8HrO4KSfyxYZ7eN1WNK61fyUh23nTHCGmNXaHeA-rJ-pGC4l-HM3TrkLs_d_w6tU68ebng_89eSFSAOgJucZiz1e1pusLgRIc3jHz6pbdu0jGtmuWTNWml59xsFV51C</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1938849889</pqid></control><display><type>article</type><title>The efficacy of tranexamic acid in reducing blood loss in total shoulder arthroplasty: A meta-analysis</title><source>HEAL-Link subscriptions: Lippincott Williams &amp; Wilkins</source><source>IngentaConnect Journals</source><source>PubMed Central</source><creator>He, Jing ; Wang, Xi-e ; Yuan, Guo-Hong ; Zhang, Lian-Hai</creator><creatorcontrib>He, Jing ; Wang, Xi-e ; Yuan, Guo-Hong ; Zhang, Lian-Hai</creatorcontrib><description>The purpose of this meta-analysis is to compare the efficacy of tranexamic acid (TXA) versus placebo after a total shoulder arthroplasty (TSA). In April 2017, a systematic computer-based search was conducted in the databases of PubMed, Embase, Web of Science, Cochrane Library, and Google. Studies comparing TXA versus placebo in reducing blood loss after TSA were included. The endpoints were the need for transfusion, blood loss in drainage, hemoglobin drop, and total blood loss. Stata 12.0 software was used for the meta-analysis. Six studies involving a total of 637 patients met the inclusion criteria. The meta-analysis revealed that, compared with control groups, treatment with TXA could decrease the need for transfusion (P &lt; .00001), blood loss in drainage (P = .000), hemoglobin drop (P = .001), and total blood loss (P = .000). TXA can decrease the need for transfusion as well as total blood loss in TSA patients. There was a negative correlation between the TXA dose and the need for transfusion and blood loss in drainage. Because the administration route and the dose of TXA were different, more studies are needed in order to identify the optimal dose and route.</description><identifier>ISSN: 0025-7974</identifier><identifier>EISSN: 1536-5964</identifier><identifier>DOI: 10.1097/MD.0000000000007880</identifier><identifier>PMID: 28906369</identifier><language>eng</language><publisher>United States: The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved</publisher><subject>Antifibrinolytic Agents - therapeutic use ; Arthroplasty, Replacement, Shoulder ; Blood Loss, Surgical - prevention &amp; control ; Humans ; Systematic Review and Meta-Analysis ; Tranexamic Acid - therapeutic use ; Treatment Outcome</subject><ispartof>Medicine (Baltimore), 2017-09, Vol.96 (37), p.e7880-e7880</ispartof><rights>The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved.</rights><rights>Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2851-ab6407f0736d9d8a6638789e1bdf5a4140a26f5c1b0427ae5f116ed8f157ece43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604638/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604638/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28906369$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>He, Jing</creatorcontrib><creatorcontrib>Wang, Xi-e</creatorcontrib><creatorcontrib>Yuan, Guo-Hong</creatorcontrib><creatorcontrib>Zhang, Lian-Hai</creatorcontrib><title>The efficacy of tranexamic acid in reducing blood loss in total shoulder arthroplasty: A meta-analysis</title><title>Medicine (Baltimore)</title><addtitle>Medicine (Baltimore)</addtitle><description>The purpose of this meta-analysis is to compare the efficacy of tranexamic acid (TXA) versus placebo after a total shoulder arthroplasty (TSA). In April 2017, a systematic computer-based search was conducted in the databases of PubMed, Embase, Web of Science, Cochrane Library, and Google. Studies comparing TXA versus placebo in reducing blood loss after TSA were included. The endpoints were the need for transfusion, blood loss in drainage, hemoglobin drop, and total blood loss. Stata 12.0 software was used for the meta-analysis. Six studies involving a total of 637 patients met the inclusion criteria. The meta-analysis revealed that, compared with control groups, treatment with TXA could decrease the need for transfusion (P &lt; .00001), blood loss in drainage (P = .000), hemoglobin drop (P = .001), and total blood loss (P = .000). TXA can decrease the need for transfusion as well as total blood loss in TSA patients. There was a negative correlation between the TXA dose and the need for transfusion and blood loss in drainage. Because the administration route and the dose of TXA were different, more studies are needed in order to identify the optimal dose and route.</description><subject>Antifibrinolytic Agents - therapeutic use</subject><subject>Arthroplasty, Replacement, Shoulder</subject><subject>Blood Loss, Surgical - prevention &amp; control</subject><subject>Humans</subject><subject>Systematic Review and Meta-Analysis</subject><subject>Tranexamic Acid - therapeutic use</subject><subject>Treatment Outcome</subject><issn>0025-7974</issn><issn>1536-5964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpdUU1v1DAQtRCILoVfgIR85JJiJ_7kgFS1fEmtuJSzNXHGjcEbL3ZC2X9PypaqMJeRZt68NzOPkJecnXBm9ZvL8xP2ILQx7BHZcNmpRlolHpMNY61stNXiiDyr9RtjvNOteEqOWmOZ6pTdkHA1IsUQoge_pznQucCEv2AbPQUfBxonWnBYfJyuaZ9yHmjKtd6W5zxDonXMSxqwUCjzWPIuQZ33b-kp3eIMDUyQ9jXW5-RJgFTxxV0-Jl8_vL86-9RcfPn4-ez0ovGtkbyBXgmmA9OdGuxgQKnOaGOR90OQILhg0KogPe-ZaDWgDJwrHEzgUqNH0R2Tdwfe3dJvcfA4rfcktytxC2XvMkT3b2eKo7vOP51UTKxiK8HrO4KSfyxYZ7eN1WNK61fyUh23nTHCGmNXaHeA-rJ-pGC4l-HM3TrkLs_d_w6tU68ebng_89eSFSAOgJucZiz1e1pusLgRIc3jHz6pbdu0jGtmuWTNWml59xsFV51C</recordid><startdate>20170901</startdate><enddate>20170901</enddate><creator>He, Jing</creator><creator>Wang, Xi-e</creator><creator>Yuan, Guo-Hong</creator><creator>Zhang, Lian-Hai</creator><general>The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved</general><general>Wolters Kluwer Health</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170901</creationdate><title>The efficacy of tranexamic acid in reducing blood loss in total shoulder arthroplasty: A meta-analysis</title><author>He, Jing ; Wang, Xi-e ; Yuan, Guo-Hong ; Zhang, Lian-Hai</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2851-ab6407f0736d9d8a6638789e1bdf5a4140a26f5c1b0427ae5f116ed8f157ece43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Antifibrinolytic Agents - therapeutic use</topic><topic>Arthroplasty, Replacement, Shoulder</topic><topic>Blood Loss, Surgical - prevention &amp; control</topic><topic>Humans</topic><topic>Systematic Review and Meta-Analysis</topic><topic>Tranexamic Acid - therapeutic use</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>He, Jing</creatorcontrib><creatorcontrib>Wang, Xi-e</creatorcontrib><creatorcontrib>Yuan, Guo-Hong</creatorcontrib><creatorcontrib>Zhang, Lian-Hai</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medicine (Baltimore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>He, Jing</au><au>Wang, Xi-e</au><au>Yuan, Guo-Hong</au><au>Zhang, Lian-Hai</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The efficacy of tranexamic acid in reducing blood loss in total shoulder arthroplasty: A meta-analysis</atitle><jtitle>Medicine (Baltimore)</jtitle><addtitle>Medicine (Baltimore)</addtitle><date>2017-09-01</date><risdate>2017</risdate><volume>96</volume><issue>37</issue><spage>e7880</spage><epage>e7880</epage><pages>e7880-e7880</pages><issn>0025-7974</issn><eissn>1536-5964</eissn><abstract>The purpose of this meta-analysis is to compare the efficacy of tranexamic acid (TXA) versus placebo after a total shoulder arthroplasty (TSA). In April 2017, a systematic computer-based search was conducted in the databases of PubMed, Embase, Web of Science, Cochrane Library, and Google. Studies comparing TXA versus placebo in reducing blood loss after TSA were included. The endpoints were the need for transfusion, blood loss in drainage, hemoglobin drop, and total blood loss. Stata 12.0 software was used for the meta-analysis. Six studies involving a total of 637 patients met the inclusion criteria. The meta-analysis revealed that, compared with control groups, treatment with TXA could decrease the need for transfusion (P &lt; .00001), blood loss in drainage (P = .000), hemoglobin drop (P = .001), and total blood loss (P = .000). TXA can decrease the need for transfusion as well as total blood loss in TSA patients. There was a negative correlation between the TXA dose and the need for transfusion and blood loss in drainage. Because the administration route and the dose of TXA were different, more studies are needed in order to identify the optimal dose and route.</abstract><cop>United States</cop><pub>The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved</pub><pmid>28906369</pmid><doi>10.1097/MD.0000000000007880</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0025-7974
ispartof Medicine (Baltimore), 2017-09, Vol.96 (37), p.e7880-e7880
issn 0025-7974
1536-5964
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5604638
source HEAL-Link subscriptions: Lippincott Williams & Wilkins; IngentaConnect Journals; PubMed Central
subjects Antifibrinolytic Agents - therapeutic use
Arthroplasty, Replacement, Shoulder
Blood Loss, Surgical - prevention & control
Humans
Systematic Review and Meta-Analysis
Tranexamic Acid - therapeutic use
Treatment Outcome
title The efficacy of tranexamic acid in reducing blood loss in total shoulder arthroplasty: A meta-analysis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T21%3A54%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20efficacy%20of%20tranexamic%20acid%20in%20reducing%20blood%20loss%20in%20total%20shoulder%20arthroplasty:%20A%20meta-analysis&rft.jtitle=Medicine%20(Baltimore)&rft.au=He,%20Jing&rft.date=2017-09-01&rft.volume=96&rft.issue=37&rft.spage=e7880&rft.epage=e7880&rft.pages=e7880-e7880&rft.issn=0025-7974&rft.eissn=1536-5964&rft_id=info:doi/10.1097/MD.0000000000007880&rft_dat=%3Cproquest_pubme%3E1938849889%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2851-ab6407f0736d9d8a6638789e1bdf5a4140a26f5c1b0427ae5f116ed8f157ece43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1938849889&rft_id=info:pmid/28906369&rfr_iscdi=true